These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. "Conformational dynamics of C1r inhibitor proteins from Lyme disease and relapsing fever spirochetes". Roy S; Booth CE; Powell-Pierce AD; Schulz AM; Skare JT; Garcia BL bioRxiv; 2023 Mar; ():. PubMed ID: 36909632 [TBL] [Abstract][Full Text] [Related]
4. Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes. Xie J; Zhi H; Garrigues RJ; Keightley A; Garcia BL; Skare JT PLoS Pathog; 2019 Mar; 15(3):e1007659. PubMed ID: 30897158 [TBL] [Abstract][Full Text] [Related]
5. Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex. Garcia BL; Zhi H; Wager B; Höök M; Skare JT PLoS Pathog; 2016 Jan; 12(1):e1005404. PubMed ID: 26808924 [TBL] [Abstract][Full Text] [Related]
6. A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes. Garrigues RJ; Powell-Pierce AD; Hammel M; Skare JT; Garcia BL J Immunol; 2021 Dec; 207(11):2856-2867. PubMed ID: 34759015 [TBL] [Abstract][Full Text] [Related]
7. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing. Pereira MJ; Wager B; Garrigues RJ; Gerlach E; Quinn JD; Dowdell AS; Osburne MS; Zückert WR; Kraiczy P; Garcia BL; Leong JM Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2117770119. PubMed ID: 35312359 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion. Damm AS; Reyer F; Langhoff L; Lin YP; Falcone FH; Kraiczy P Front Immunol; 2024; 15():1390468. PubMed ID: 38726006 [TBL] [Abstract][Full Text] [Related]
9. The molecular determinants of classical pathway complement inhibition by OspEF-related proteins of Borrelia burgdorferi. Thomas S; Schulz AM; Leong JM; Zeczycki TN; Garcia BL J Biol Chem; 2024 May; 300(5):107236. PubMed ID: 38552741 [TBL] [Abstract][Full Text] [Related]
10. Complement evasion strategies of Borrelia burgdorferi sensu lato. Dulipati V; Meri S; Panelius J FEBS Lett; 2020 Aug; 594(16):2645-2656. PubMed ID: 32748966 [TBL] [Abstract][Full Text] [Related]
11. The Complement Binding and Inhibitory Protein CbiA of Nguyen NTT; Röttgerding F; Devraj G; Lin YP; Koenigs A; Kraiczy P Front Cell Infect Microbiol; 2018; 8():23. PubMed ID: 29456970 [TBL] [Abstract][Full Text] [Related]
16. Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s. Garrigues RJ; Thomas S; Leong JM; Garcia BL J Biol Chem; 2022 Nov; 298(11):102557. PubMed ID: 36183830 [TBL] [Abstract][Full Text] [Related]
17. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Li X; Liu X; Beck DS; Kantor FS; Fikrig E Infect Immun; 2006 Jun; 74(6):3305-13. PubMed ID: 16714558 [TBL] [Abstract][Full Text] [Related]
18. Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Fischer JR; LeBlanc KT; Leong JM Infect Immun; 2006 Jan; 74(1):435-41. PubMed ID: 16368999 [TBL] [Abstract][Full Text] [Related]
19. Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Stone BL; Brissette CA Front Immunol; 2017; 8():12. PubMed ID: 28154563 [TBL] [Abstract][Full Text] [Related]